Insmed (INSM) PT Lowered to $185 at Truist Securities
Truist Securities analyst Danielle Brill lowered the price target on Insmed (NASDAQ: INSM) to $185.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
